Source: http://www.google.com/patents/US20020058855?dq=5,815,794
Timestamp: 2017-03-29 01:02:59
Document Index: 556877864

Matched Legal Cases: ['art. 12', 'art. 13', 'art. 14', 'art. 18', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 40', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14', 'art 14']

Patent US20020058855 - Heart wall tension reduction apparatus and method - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn apparatus for treatment of a failing heart by reducing the wall tension therein. In one embodiment, the apparatus includes a tension member for drawing at least two walls of a heart chamber toward each other. Methods for placing the apparatus on the heart are also provided....http://www.google.com/patents/US20020058855?utm_source=gb-gplus-sharePatent US20020058855 - Heart wall tension reduction apparatus and methodAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS20020058855 A1Publication typeApplicationApplication numberUS 09/985,362Publication dateMay 16, 2002Filing dateNov 2, 2001Priority dateJan 2, 1997Also published asCA2275766A1, CA2275766C, DE69737955T2, EP1011461A1, EP1011461A4, EP1011461B1, US6050936, US6059715, US6162168, US6165119, US6165120, US6332863, US6332864, US6514194, US6589160, US6755777, US6793618, US7695425, US20020068849, US20020077524, US20030166992, US20030171641, US20040167374, US20090137863, WO1998029041A1Publication number09985362, 985362, US 2002/0058855 A1, US 2002/058855 A1, US 20020058855 A1, US 20020058855A1, US 2002058855 A1, US 2002058855A1, US-A1-20020058855, US-A1-2002058855, US2002/0058855A1, US2002/058855A1, US20020058855 A1, US20020058855A1, US2002058855 A1, US2002058855A1InventorsCyril Schweich, Todd MortierOriginal AssigneeMyocor, Inc.Export CitationBiBTeX, EndNote, RefManReferenced by (123), Classifications (25), Legal Events (6) External Links: USPTO, USPTO Assignment, EspacenetHeart wall tension reduction apparatus and method
US 20020058855 A1Abstract
An apparatus for treatment of a failing heart by reducing the wall tension therein. In one embodiment, the apparatus includes a tension member for drawing at least two walls of a heart chamber toward each other. Methods for placing the apparatus on the heart are also provided. Images(12) Claims(24)
What is claimed is: 1. A heart wall tension reduction apparatus, comprising: a first tension member having two oppositely disposed ends; and first and second anchor members, the first anchor member being disposed proximate one end of the tension member and the second anchor member being disposed proximate the opposite end of the tension member. 2. The heart wall tension reduction apparatus in accordance with claim 1, wherein the first anchor member comprises a first pad having a length and a width, and the second anchor member comprises a second pad having a length and a width, and the first and second pad each have two lengthwise ends. 3. The heart wall tension reduction apparatus in accordance with claim 2, wherein the length of the pads is greater than the width of the respective pad. 4. A heart wall tension reduction apparatus in accordance with claim 2, further comprising a second tension member having two oppositely disposed ends; and one lengthwise end of the first pad is disposed proximate one end of the first tension member, and the opposite lengthwise end of the first pad is disposed proximate one end of the second tension member, and one lengthwise end of the second pad is disposed proximate the end of the first tension member opposite the first pad, and the opposite lengthwise of the second pad is disposed proximate the end of the second tension member opposite the first pad. 5. The heart wall tension reduction apparatus in accordance with claim 4, wherein the length of the first pad is greater than the width of the respective pads. 6. The heart wall tension reduction apparatus in accordance with claim 1, further comprising a third anchor member, and a second tension member having two oppositely disposed ends; wherein the third anchor member is disposed proximate one end of the second tension member and the first anchor member is disposed proximate the opposite end of the second tension member. 7. The heart wall tension reduction apparatus in accordance with claim 6, wherein the first anchor member comprises a first pad having a length and width, and the second anchor member comprises a second pad having a length and a width, and the first and second pads each have two lengthwise ends. 8. The heart wall tension reduction apparatus in accordance with claim 7, wherein the length of the pads is greater than the width of the respective pad. 9. The heart wall tension reduction apparatus, comprising: an elongate compression member having first and second ends; first and second elongate lever members, the first lever member extending from the first end of the compression member, and the second lever member extending from the second end of the compression member; and a tension member extending between the first and second lever members. 10. A heart wall tension reduction apparatus in accordance with claim 9, wherein each of the two lever members have two ends, one end of each of the two lever members is disposed proximate the compression member, the other end of each of the two lever members is disposed remotely from the compression member, and the tension member is disposed closer to the ends of the two lever members disposed proximate the compression member than the ends disposed remotely therefrom. 11. A method of disposing a heart wall tension reduction apparatus on a human heart having a plurality of chambers, comprising the steps of: providing a heart wall tension reduction apparatus including an elongate compression member having first and second ends; first and second elongate lever members, the first lever member extending from the first end of the compression member, and the second lever member extending from the second end of the compression member; a tension member extending between the first and second lever members; and extending the tension member through at least one chamber of the human heart. 12. A method in accordance with claim 11, further comprising the step of disposing the compression member external to the heart. 13. The method in accordance with claim 11, further comprising the step of disposing at least a portion of the compression member within the heart. 14. A heart wall tension reduction apparatus, comprising: a rigid elongate frame member having a first end and a second end; a first cantilever member disposed at the first end of the frame member; and a second cantilever member disposed at the second end of the frame member. 15. A heart wall tension reduction apparatus in accordance with claim 14, wherein each cantilever member includes at least one atraumatic pad disposed thereon. 16. A heart wall tension reduction apparatus in accordance with claim 14, further comprising a plurality of cantilever members disposed at the first and second ends of the frame member. 17. The method of placing a heart wall tension reduction apparatus on a human heart having a plurality of chambers, comprising the steps of: extending a hollow needle through at least one chamber of the heart such that each end of the needle is external to the chamber; providing a tension member having first and second ends, and a flexible leader connected to the first end of the tension member; connecting the second end of the tension member to a first atraumatic pad; advancing the leader through the needle from one end of the needle to the other; further advancing the leader until the first atraumatic pad engages the heart and the first end of the tension member is external to the at least one chamber; and connecting the first end of the tension member to a second atraumatic pad such that the second atraumatic pad engages the heart. 18. The method in accordance with claim 17, wherein the length of the tension member is such that the at least one chamber of the heart is compressed between the first and second atraumatic pads. 19. The method of placing a heart wall tension reduction apparatus on a heart having a plurality of chambers, comprising the steps of: extending a guide member through at least one chamber of the heart such that each end of the guide member is external to the chamber; providing a tension member having at least one lumen extending therethrough; extending a portion of the guide member through the lumen; advancing the tension member on the guide member such that a first end of the tension member is disposed to one side of and external to the at least one chamber, and a second end of the tension member is disposed to an opposite side of and external to the at least one chamber; and connecting a first atraumatic pad to the first end and a second atraumatic pad to the second end of the tension member. 20. The method in accordance with claim 19, wherein the length of the tension member is such that the at least one chamber of the heart is compressed between the first and second atraumatic pads. 21. A method in accordance with claim 19, wherein the guide member includes a needle. 22. The method in accordance with claim 19, wherein the guide member includes a guidewire. 23. The method of placing a heart wall tension reduction apparatus on a heart having a plurality of chamber comprising the steps of: extending a needle having a flexible tension member releasably connected thereto through at least one chamber of the heart such that opposite ends of the tension member are external to the chamber and exposed on opposite sides thereof; removing the needle from the tension member; and connecting a first atraumatic pad to one end of the tension member and a second atraumatic pad to the opposite end of the tension member. 24. A method in accordance with claim 23, wherein the length of the tension member is such that the at least one chamber of the heart is compressed between the first and second atraumatic pads.
CROSS REFERENCE TO RELATED APPLICATION [0001] This application is a continuation-in-part of U.S. application Ser. No. 08/778,277, filed Jan. 2, 1997, entitled “HEART WALL TENSION REDUCTION APPARATUS”.
FIELD OF THE INVENTION [0002] The present invention pertains to the field of apparatus for treatment of a failing heart. In particular, the apparatus of the present invention is directed toward reducing the wall stress in the failing heart. BACKGROUND OF THE INVENTION [0003] The syndrome of heart failure is a common course for the progression of many forms of heart disease. Heart failure may be considered to be the condition in which an abnormality of cardiac function is responsible for the inability of the heart to pump blood at a rate commensurate with the requirements of the metabolizing tissues, or can do so only at an abnormally elevated filling pressure. There are many specific disease processes that can lead to heart failure with a resulting difference in pathophysiology of the failing heart, such as the dilatation of the left ventricular chamber. Etiologies that can lead to this form of failure include idiopathic cardiomyopathy, viral cardiomyopathy, and ischemic cardiomyopathy. [0004] The process of ventricular dilatation is generally the result of chronic volume overload or specific damage to the myocardium. In a normal heart that is exposed to long term increased cardiac output requirements, for example, that of an athlete, there is an adaptive process of slight ventricular dilation and muscle myocyte hypertrophy. In this way, the heart fully compensates for the increased cardiac output requirements. With damage to the myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate. [0005] The basic problem with a large dilated left ventricle is that there is a significant increase in wall tension and/or stress both during diastolic filling and during systolic contraction. In a normal heart, the adaptation of muscle hypertrophy (thickening) and ventricular dilatation maintain a fairly constant wall tension for systolic contraction. However, in a failing heart, the ongoing dilatation is greater than the hypertrophy and the result is a rising wall tension requirement for systolic contraction. This is felt to be an ongoing insult to the muscle myocyte resulting in further muscle damage. The increase in wall stress is also true for diastolic filling. Additionally, because of the lack of cardiac output, there is generally a rise in ventricular filling pressure from several physiologic mechanisms. Moreover, in diastole there is both a diameter increase and a pressure increase over normal, both contributing to higher wall stress levels. The increase in diastolic wall stress is felt to be the primary contributor to ongoing dilatation of the chamber. [0006] Prior art treatments for heart failure fall into three generally categories. The first being pharmacological, for example, diuretics. The second being assist systems, for example, pumps. Finally, surgical treatments have been experimented with, which are described in more detail below. [0007] With respect to pharmacological treatments, diuretics have been used to reduce the workload of the heart by reducing blood volume and preload. Clinically, preload is defined in several ways including left ventricular end diastolic pressure (LVEDP), or left ventricular end diastolic volume (LVEDV) Physiologically, the preferred definition is the length of stretch of the sarcomere at end diastole. Diuretics reduce extra cellular fluid which builds in congestive heart failure patients increasing preload conditions. Nitrates, arteriolar vasodilators, angiotensin converting enzyme inhibitors have been used to treat heart failure through the reduction of cardiac workload through the reduction of afterload. Afterload may be defined as the tension or stress required in the wall of the ventricle during ejection. Inotropes like digoxin are cardiac glycosides and function to increase cardiac output by increasing the force and speed of cardiac muscle contraction. These drug therapies offer some beneficial effects but do not stop the progression of the disease. [0008] Assist devices include mechanical pumps and electrical stimulators. Mechanical pumps reduce the load on the heart by performing all or part of the pumping function normally done by the heart. Currently, mechanical pumps are used to sustain the patient while a donor heart for transplantation becomes available for the patient. Electrical stimulation such as bi-ventricular pacing have been investigated for the treatment of patients with dilated cardiomyopathy. [0009] There are at least three surgical procedures for treatment of heart failure: 1) heart transplant; 2) dynamic cardiomyoplasty; and 3) the Batista partial left ventriculectomy. Heart transplantation has serious limitations including restricted availability of organs and adverse effects of immunosuppressive therapies required following heart transplantation. Cardiomyoplasty includes wrapping the heart with skeletal muscle and electrically stimulating the muscle to contract synchronously with the heart in order to help the pumping function of the heart. The Batista partial left ventriculectomy includes surgically remodeling the left ventricle by removing a segment of the muscular wall. This procedure reduces the diameter of the dilated heart, which in turn reduces the loading of the heart. However, this extremely invasive procedure reduces muscle mass of the heart. SUMMARY OF THE INVENTION [0010] The present invention pertains to a non-pharmacological, passive apparatus and method for the treatment of a failing heart. The device is configured to reduce the tension in the heart wall. It is believed to reverse, stop or slow the disease process of a failing heart as it reduces the energy consumption of the failing heart, decreases isovolumetric contraction, increases sarcomere shortening during contraction and increases isotonic shortening which in turn increases stroke volume. The device reduces wall tension during diastole and systole. [0011] In one embodiment, the apparatus includes a tension member for drawing at least two walls of the heart chamber toward each other to reduce the radius or area of the heart chamber in at least one cross sectional plane. The tension member has anchoring members disposed at opposite ends for engagement with the heart or chamber wall. [0012] In another embodiment, the apparatus includes a compression member for drawing at least two walls of a heart chamber toward each other. In one embodiment, the compression member includes a balloon. In another embodiment of the apparatus, a frame is provided for supporting the compression member. [0013] Yet another embodiment of the invention includes a clamp having two ends biased toward one another for drawing at least two walls of a heart chamber toward each other. The clamp includes at least two ends having atraumatic anchoring member disposed thereon for engagement with the heart or chamber wall. [0014] In yet another embodiment, a heart wall tension reduction apparatus is provided which includes a first tension member having two oppositely disposed ends and first and second elongate anchor members. A second tension member can be provided. One of the elongate anchors may be substituted for by two smaller anchors. [0015] In an alternate embodiment of the heart wall tension reduction apparatus, an elongate compression member can be provided. First and second elongate lever members preferably extend from opposite ends of the compression member. A tension member extends between the first and second lever members. [0016] The compression member of the above embodiment can be disposed exterior to, or internally of the heart. The tension member extends through the chamber or chambers to bias the lever members toward the heart. [0017] In yet another embodiment of a heart wall tension reduction apparatus in accordance with the present invention, a rigid elongate frame member is provided. The frame member can extend through one or more chambers of the heart. One or more cantilever members can be disposed at opposite ends of the frame member. Each cantilever member includes at least ore atraumatic pad disposed thereon. The atraumatic pads disposed at opposite ends of the frame member can be biased toward each other to compress the heart chamber. [0018] One method of placing a heart wall tension apparatus or splint on the human heart includes the step of extending a hollow needle through at least one chamber of the heart such that each end of the needle is external to the chamber. A flexible leader is connected to a first end of a tension member. A second end of the tension member is connected to an atraumatic pad. The leader is advanced through the needle from one end of the needle to the other. The leader is further advanced until the second end of the tension member is proximate the heart and the first end of the tension member is external to the heart. A second atraumatic pad is connected to the first end of the tension member such that the first and second atraumatic pads engage the heart. [0019] An alternate method of placing the heart wall tension reduction apparatus on the heart includes the step of extending a guide member through at least one chamber of the heart such that each end of the guide member is external to the chamber. A tension member for use in this method has at least one lumen extending through at least a portion of the member. The guide member is placed in the lumen. The tension member is advanced over the guide member such that a first end of the tension member is disposed to one side of and external to the heart and a second end of the tension member is disposed to an opposite side of and external to the heart. A first atraumatic pad is connected to one end of the tension member and a second atraumatic pad is connected to the opposite end of the tension member. [0020] Yet another method of placing a heart wall tension apparatus on a heart includes the step of extending a needle having a flexible tension member releasably connected thereto through at least one chamber of the heart such that opposite ends of the tension member are external to the chamber and exposed on opposite sides of the chamber. The needle is removed from the tension member. Then first and second atraumatic pads are connected to the tension member at opposite ends of the tension member.
BRIEF DESCRIPTION OF THE DRAWINGS [0021] [0021]FIG. 1 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a splint in accordance with the present invention; [0022] [0022]FIG. 2 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a balloon device in accordance with the present invention; [0023] [0023]FIG. 3 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of an external compression frame structure in accordance with the present invention; [0024] [0024]FIG. 4 is a transverse cross-section of the left and right ventricles of a human heart showing a clamp in accordance with the present invention; [0025] [0025]FIG. 5 is a transverse cross-section of the left and right ventricles of a human heart showing a three tension member version of the splint of FIG. 1; [0026] [0026]FIG. 6 is a transverse cross-section of the left and right ventricles of a human heart showing a four tension member version of the splint shown in FIG. 1; [0027] [0027]FIG. 7 is a vertical cross-sectional view of the left ventricle of a human heart showing an alternate version of the splint in accordance with the present invention; [0028] [0028]FIG. 8 is an end of the splint shown in FIG. 7; [0029] [0029]FIG. 9 is a vertical cross-sectional view of a chamber of a human heart showing another alternative embodiment of the splint in accordance with the present invention; [0030] [0030]FIG. 10 is a vertical cross-section of a chamber of a human heart showing another alternative configuration or splints in accordance with the present invention; [0031] [0031]FIG. 11 is a vertical cross-sectional view of a chamber of a human heart showing another embodiment of a splint in accordance with the present invention; [0032] [0032]FIG. 12 is a vertical cross-sectional view of a chamber of a human heart showing another embodiment of the splint in accordance with the present invention; [0033] [0033]FIG. 13 is a vertical cross-sectional view of a chamber of a human heart showing a compression member version of the splint in accordance with the present invention; [0034] [0034]FIG. 14 is a vertical cross-sectional view of a chamber of a human heart showing another version of the splint shown in FIG. 13; [0035] [0035]FIG. 15 is a vertical cross-sectional view of a chamber of a human heart showing a frame member version of the splint in accordance with the present invention; [0036] [0036]FIG. 16 is an end view of the splint of FIG. 15; [0037] [0037]FIG. 17 is a vertical cross-section of the left ventricle and atrium, the left ventricle having scar tissue; [0038] [0038]FIG. 18 is a vertical cross-section of the heart of FIG. 7 showing the splint of FIG. 1 drawing the scar tissue toward the opposite wall of the left ventricle; [0039] [0039]FIG. 19 is a vertical cross-section of the left ventricle and atrium of a human heart showing a version of the splint of FIG. 1 having an elongate anchor bar; [0040] [0040]FIG. 20 is a side view of an undeployed hinged anchor member; [0041] [0041]FIG. 21 is a side view of a deployed hinged anchor member of FIG. 10; [0042] [0042]FIG. 22 is a cross-sectional view of an captured ball anchor member; [0043] [0043]FIG. 23 is a perspective view of a cross bar anchor member; [0044] [0044]FIG. 24 is a vertical cross-sectional view of a chamber of a human heart showing a needle used for placement of splint in accordance with the present invention; [0045] [0045]FIG. 25 is a view of the heart and needle of FIG. 24 showing a tension member being placed in the heart; [0046] [0046]FIG. 26 is a view of the heart shown in FIG. 24 wherein oppositely disposed anchor pads are being joined by a tension member; [0047] [0047]FIG. 27 is a view of the heart of FIG. 24, wherein two oppositely disposed anchor pads have been joined by two tension members; [0048] [0048]FIG. 28 is a view of a tension member having a lumen extending therethrough; [0049] [0049]FIG. 29 is a view of a tension member having lumens extending therethrough; [0050] [0050]FIG. 30 is a vertical cross-sectional view of a chamber of the heart and two pads, and a needle extending therethrough; [0051] [0051]FIG. 31 is a vertical cross-sectional view of a chamber of the heart showing a guidewire extending therethrough; [0052] [0052]FIG. 32 is a view of the heart of FIG. 31, and two pads, and a guidewire extending therethrough; [0053] [0053]FIG. 33 is a vertical cross-sectional view of a chamber of the heart showing a needle connected to a tension member being inserted into the chamber; [0054] [0054]FIG. 34 is a vertical cross-sectional view of a chamber of a heart showing two anchors connected by a tension member; [0055] [0055]FIG. 35 is a vertical cross-sectional view of a chamber of the heart, showing a band surrounding the heart; [0056] [0056]FIG. 36 is a idealized cylindrical model of a left ventricle of a human heart; [0057] [0057]FIG. 37 is a splinted model of the left ventricle of FIG. 14; [0058] [0058]FIG. 38 is a transverse cross-sectional view of FIG. 15 showing various modeling parameters; [0059] [0059]FIG. 39 is a transverse cross-section of the splinted left ventricle of FIG. 15 showing a hypothetical force distribution; and [0060] [0060]FIG. 40 is a second transverse cross-sectional view of the model left ventricle of FIG. 15 showing a hypothetical force distribution.
DETAILED DESCRIPTION OF THE INVENTION [0061] Referring now to the drawings wherein like reference numerals refer to like elements throughout the several views, FIG. 1 shows a transverse cross-section of a left ventricle 10 and a right ventricle 12 of a human heart 14. Extending through the left ventricle is a splint 16 including a tension member 18 and oppositely disposed anchors 20. Splint 16 as shown in FIG. 1 has been positioned to draw opposite walls of left ventricle 10 toward each other to reduce the “radius” of the left ventricular cross-section or the cross-sectional area thereof to reduce left ventricular wall stresses. It should be understood that although the splint 16 and the alternative devices disclosed herein are described in relation to the left ventricle of a human heart, these devices could also be used to reduce the radius or cross-sectional area of the other chambers of a human heart in transverse or vertical directions, or at an angle between the transverse and vertical. [0062] [0062]FIG. 2 discloses an alternate embodiment of the present invention, wherein a balloon 200 is deployed adjacent the left ventricle. The size and degree of inflation of the balloon can be varied to reduce the radius or cross-sectional area of left ventricle 10 of heart 14. [0063] [0063]FIG. 3 shows yet another alternative embodiment of the present invention deployed with respect to left ventricle 10 of human heart 14. Here a compression frame structure 300 is engaged with heart 14 at atraumatic anchor pads 310. A compression member 312 having an atraumatic surface 314 presses against a wall of left ventricle 10 to reduce the radius or cross-sectional area thereof. [0064] [0064]FIG. 4 is a transverse cross-sectional view of human heart 14 showing yet another embodiment of the present invention. In this case a clamp 400 having atraumatic anchor pads 410 biased toward each other is shown disposed on a wall of left ventricle 10. Here the radius or cross-sectional area of left ventricle 10 is reduced by clamping off the portion of the wall between pads 410. Pads 410 can be biased toward each other and/or can be held together by a locking device. [0065] Each of the various embodiments of the present invention disclosed in FIGS. 1-4 can be made from materials which can remain implanted in the human body indefinitely. Such biocompatible materials are well-known to those skilled in the art of clinical medical devices. [0066] [0066]FIG. 5 shows an alternate embodiment of the splint of FIG. 1 referred to in FIG. 5 by the numeral 116. The embodiment 116 shown in FIG. 5 includes three tension members 118 as opposed to a single tension member 18 as shown in FIG. 1. FIG. 6 shows yet another embodiment of the splint 216 having four tension members 218. It is anticipated that in some patients, the disease process of the failing heart may be so advanced that three, four or more tension members may be desirable to reduce the heart wall stresses more substantially than possible with a single tension member as shown in FIG. 1. [0067] [0067]FIG. 7 is a partial vertical cross-section of human heart 14 showing left ventricle 10. In FIG. 7, another splint embodiment 316 is shown having a tension member 318 extending through left ventricle 10. On opposite ends of tension member 318 are disposed elongate anchors or pads 320. FIG. 8 is an end view of tension member 318 showing elongate anchor 320. [0068] [0068]FIG. 9 shows another embodiment of a splint 416 disposed in a partial vertical cross-section of human heart 14. Splint 416 includes two elongate anchors or pads 420 similar to those shown in FIGS. 7 and 8. In FIG. 9, however, two tension members 418 extend through left ventricle 10 to interconnect anchors 420 on opposite sides of heart 14. [0069] [0069]FIG. 10 is a vertical cross section of heart 14 showing left ventricle 10. In this case, two splints 16 are disposed through left ventricle 10 and vertically spaced from each other to resemble the configuration of FIG. 9. [0070] [0070]FIG. 11 is a vertical cross sectional view of the left ventricle of heart 14. Two alternate embodiment splints 516 are shown extending through left ventricle 10. Each splint 516 includes two tension members 518 interconnecting two anchors or pads 520. [0071] [0071]FIG. 12 is yet another vertical cross sectional view of left ventricle 10 of heart 14. An alternate embodiment 616 of the splint is shown extending through left ventricle 10. Splint 616 includes an elongate anchor pad 620 and two shorter anchors or pads 621. Splint 616 includes two tension members 618. Each tension member 618 extends between anchors 620 and respective anchors 621. [0072] [0072]FIG. 13 is a vertical cross sectional view of left ventricle 10 of heart 14. A splint 50 is shown disposed on heart 14. Splint 50 includes a compression member 52 shown extending through left ventricle 10. Opposite ends of compression member 52 are disposed exterior to left ventricle 10. Lever members 54 extend from each end of compression member 52 upwardly along the exterior surface of ventricle 10. A tension member 56 extends between lever members 54 to bias lever members 54 toward heart 14 to compress chamber 10. [0073] Compression member 52 should be substantially rigid, but lever members 54 and to some degree compression member 52 should be flexible enough to allow tension member 56 to bias lever members 54 toward heart 14. Alternately, lever members 54 could be hinged to compression member 52 such that lever members 54 could pivot about the hinge when biased toward heart 14 by tension member 56. [0074] [0074]FIG. 14 shows an alternate embodiment 156 of the splint shown in FIG. 13. In this case lever members 154 are longer than members 54 as compression member 152 of splint 150 has been disposed to the exterior of left ventricle 10. [0075] [0075]FIG. 15 is a vertical cross sectional view of left ventricle 10 of heart 14. An alternate embodiment 250 of the splint is shown on heart 14. A preferably relatively rigid frame member 256 extends through ventricle 10. Disposed on opposite ends of frame 250 are cantilever member 254. Disposed on cantilever members 254 are atraumatic pads 258. Cantilever members 254 can be positioned along frame member 256 such that atraumatic pads 258 press against heart 14 to compress chamber 10. FIG. 16 is an end view of frame member 256 showing cantilever members 254 and pads 258. [0076] It should be understood that each of the embodiments described above should be formed from suitable biocompatible materials known to those skilled in the art. The tension members can be formed from flexible or relatively more rigid material. The compression members and frame member should be formed from generally rigid material which may flex under load, but generally hold its shape. [0077] [0077]FIG. 17 is a partial vertical cross-section of human heart 14 showing left ventricle 10 and left atrium 22. As shown in FIG. 7, heart 14 includes a region of scar tissue 24 associated with an aneurysm or ischemia. As shown in FIG. 7, the scar tissue 24 increases the radius or cross-sectional area of left ventricle 10 in the region affected by the scar tissue. Such an increase in the radius or cross-sectional area of the left ventricle will result in greater wall stresses on the walls of the left ventricle. [0078] [0078]FIG. 18 is a vertical cross-sectional view of the heart 14 as shown in FIG. 7, wherein a splint 16 has been placed to draw the scar tissue 24 toward an opposite wall of left ventricle 10. As a consequence of placing splint 16, the radius or cross-sectional area of the left ventricle affected by the scar tissue 24 is reduced. The reduction of this radius or cross-sectional area results in reduction in the wall stress in the left ventricular wall and thus improves heart pumping efficiency. [0079] [0079]FIG. 19 is a vertical cross-sectional view of left ventricle 10 and left atrium 22 of heart 14 in which a splint 16 has been placed. As shown in FIG. 9, splint 16 includes an alternative anchor 26. The anchor 26 is preferably an elongate member having a length as shown in FIG. 9 substantially greater than its width (not shown). Anchor bar 26 might be used to reduce the radius or cross-sectional area of the left ventricle in an instance where there is generalized enlargement of left ventricle 10 such as in idiopathic dilated cardiomyopathy. In such an instance, bar anchor 26 can distribute forces more widely than anchor 20. [0080] [0080]FIGS. 20 and 21 are side views of a hinged anchor 28 which could be substituted for anchors 20 in undeployed and deployed positions respectively. Anchor 28 as shown in FIG. 20 includes two legs similar to bar anchor 26. Hinged anchor 28 could include additional legs and the length of those legs could be varied to distribute the force over the surface of the heart wall. In addition there could be webbing between each of the legs to give anchor 28 an umbrella-like appearance. Preferably the webbing would be disposed on the surface of the legs which would be in contact with the heart wall. [0081] [0081]FIG. 22 is a cross-sectional view of a capture ball anchor 30. Capture ball anchor 30 can be used in place of anchor 20. Capture ball anchor 30 includes a disk portion 32 to distribute the force of the anchor on the heart wall, and a recess 34 for receiving a ball 36 affixed to an end of tension member 18. Disk 32 and recess 34 include a side groove which allows tension member 38 to be passed from an outside edge of disk 32 into recess 34. Ball 36 can then be advanced into recess 34 by drawing tension member 18 through an opening 38 in recess 34 opposite disk 32. [0082] [0082]FIG. 23 is a perspective view of a cross bar anchor 40. The cross bar anchor 40 can be used in place of anchors 20. The anchor 40 preferably includes a disk or pad portion 42 having a cross bar 44 extending over an opening 46 in pad 42. Tension member 18 can be extended through opening 46 and tied to cross bar 42 as shown. [0083] In use, the various embodiments of the present invention are placed in or adjacent the human heart to reduce the radius or cross-section area of at least one chamber of the heart. This is done to reduce wall stress or tension in the heart or chamber wall to slow, stop or reverse failure of the heart. In the case of the splint 16 shown in FIG. 1, a canula can be used to pierce both walls of the heart and one end of the splint can be advanced through the canula from one side of the heart to the opposite side where an anchor can be affixed or deployed. Likewise, an anchor is affixed or deployed at the opposite end of splint 16. [0084] [0084]FIG. 24 is a vertical cross-sectional view of a chamber 10 of a heart 14. A needle 60 having a stylet inserted therethrough is inserted through chamber 10. FIG. 25 shows needle 60 disposed in heart 40 as shown in FIG. 24. In FIG. 25, stylet 6 has been removed. A tension member 64 having a flexible loader 66 attached to one end of tension member 64, is threaded through needle 60 and an anchor 68. [0085] As shown in FIG. 25, tension member 64 includes a generally elongate cylindrical shaft 70 having two generally cylindrical ends 72. Ends 72 preferably have a greater diameter than shaft 70. Also shown in FIG. 25 is a perspective view of anchor 68 showing an opening 73 extending through anchor 68. Opening 73 includes a first cylindrically shaped opening 74 extending entirely through anchor 68. The diameter of opening 74 is preferably slightly greater than the diameter of end 72 of tension member 64. A groove 76 having a width preferably slightly greater than that of shaft 70 of tension member 64 extends from opening 74 to a generally cylindrical opening 78. Generally cylindrical opening 78 has a diameter approximately equal to end 72. Unlike opening 74, however, opening 78 includes a reduced base opening 80 which has a width approximately equal to that of groove 76. The width of the opening 80 is also less than the diameter of end 72 of tension member 64. [0086] It can be appreciated that tension member 64 can be advanced through opening 74 until shaft 70 is disposed therein. Shaft 70 can be then slid transversely through groove 76. Tension member 64 can then be advanced further through opening 73 until end portion 72 enters opening 78 and seats against base 80. [0087] [0087]FIG. 26 shows the view of heart 14 shown in FIG. 25. Needle 60 has been removed from heart 14. Tension member 64 has been advanced into chamber 10 and anchor 68 connected thereto is engaging the heart wall. Leader 66 has been advanced through yet another anchor 68 disposed on the opposite side of heart 14. [0088] [0088]FIG. 27 is a view of heart 14 of FIG. 26. Two tension member 64 have been advanced through chamber 10. Each tension member has been seated in respective opening 78 against respective bases 80 to form a splint in a configuration such as that shown in FIG. 9. [0089] It can be appreciated that each of the other tension member splints configurations can be placed on the heart in a similar manner. It can also be appreciated that anchors 68 could initially be held against the heart and needle 60 advanced through anchors 68 and chamber 10 prior to extending leader 66 through the needle. [0090] [0090]FIG. 28 is a perspective view of a tension member 164 in accordance with the present invention. Tension member 164 is similar to tension member 64 described above in that it has an elongate, generally cylindrical shaft 170 and generally cylindrical ends 172. A lumen, however, extends longitudinally through tension member 164 along axis A. [0091] [0091]FIG. 29 is a perspective view of yet another embodiment of the tension member 264. Tension member 264, is similar to tension member 164, and includes an elongate cylindrical shaft 270 and cylindrical ends 272. Lumens 282, however, extend through ends 272 aligned along axis P. [0092] [0092]FIG. 30 is a vertical, cross-sectional view of left ventricle 10 of heart 14. Anchors 68 have been placed on opposite sides of heart 14. A needle 160 extends through the lumen of tension member 164, left ventricle 10 and openings 73 in anchors 68. It can be appreciated that tension member 64 can be advanced through anchors 68 and left ventricle 10 and be seated within openings 78 as described above with respect to tension member 64. [0093] [0093]FIG. 31 is a vertical, cross-sectional view of left ventricle 10 of heart 14. A needle 60 has been advanced through the wall of left ventricle 10 and a guidewire 162 has been advanced through needle 60. [0094] [0094]FIG. 32 is the same view of heart 14 as shown in FIG. 32. Needle 60, however, has been removed from heart 14 while guidewire 162 remains in position. Anchors 68 have been placed on guidewire 162, on opposite sides of left ventricle 10. Tension member 264 has been threaded onto guidewire 162 through lumens 282. It can be appreciated that as discussed above with respect to tension member 164 above, tension member 264 can be advanced through left ventricle 10 such that ends 272 of tension member 264 seat in respective openings 78 against base 80. [0095] [0095]FIG. 33 is a vertical, cross-sectional view of left ventricle 10 of heart 14. In FIG. 34, flexible tension member 364 has been connected to a needle 360. Needle 360 is shown being advanced into left ventricle 10 through a ventricle wall. [0096] [0096]FIG. 34 is the same view of heart 14 as shown in FIG. 33 except that tension member 364 has been advanced entirely through left ventricle 10 and anchors 68. Knots 384 have been tied at the ends of tension member 364 to prevent the ends of tension member 364 from passing through opening 73 of anchors 68. [0097] It can be appreciated that the methods described above to advance the tension members through the ventricles can be repeated to advance the desired number of tension members through the ventricle for a particular configuration. The length or the tension members can be determined based upon the size and condition of the patient's heart. It should also be noted that although the left ventricle has been referred to here for illustrative purposes, that the apparatus and methods of this invention can also be used to splint multiple chambers of a patient's heart as well as the right ventricle or either atrium. [0098] [0098]FIG. 35 is a vertical cross-section of left ventricle 10 of heart 14. Disposed about heart 14 is a band 716. Band 716 is shown as being sized relative to the heart such that the heart's radius or cross-sectional area in a plane parallel to the length of the band is reduced relative to the radius at that location prior to placement of the band on the heart. The length of the heart perpendicular to the band is also increased. The band may be formed from a continuous ribbon of elastomeric material or from other biocompatible materials which are sufficiently strong to provide the desired effect of heart radius reduction and lengthening. [0099] [0099]FIG. 36 is a view of a cylinder or idealized heart chamber 48 which is used to illustrate the reduction of wall stress in a heart chamber as a result of deployment of the splint in accordance with the present invention. The model used herein and the calculations related to this model are intended merely to illustrate the mechanism by which wall stress is reduced in the heart chamber. No effort is made herein to quantify the actual reduction which would be realized in any particular in vivo application. [0100] [0100]FIG. 37 is a view of the idealized heart chamber 48 of FIG. 36 wherein the chamber has been splinted along its length L such that a “figure eight” cross-section has been formed along the length thereof. It should be noted that the perimeter of the circular transverse cross-section of the chamber in FIG. 36 is equal to the perimeter of the figure eight transverse cross-section of FIG. 37. For purposes of this model, opposite lobes of the figure in cross-section are assumed to be mirror images. [0101] [0101]FIG. 38 shows various parameters of the FIG. 1 cross-section of the splinted idealized heart chamber of FIG. 37. Where l is the length of the splint between opposite walls of the chamber, R2 is the radius of each lobe, θ is the angle between the two radii of one lobe which extends to opposite ends of the portion of the splint within chamber 48 and h is the height of the triangle formed by the two radii and the portion of the splint within the chamber 48 (R1 is the radius of the cylinder of FIG. 36). These various parameters are related as follows: [0102] h=R2 COS (θ/2) [0103] l=2 R2 SIN (θ/2) [0104] R2=R1π/ (2π−θ) [0105] From these relationships, the area of the figure eight cross-section can be calculated by:
A 2=2π(R 2)2(1−θ/2π)+hl [0106] Where chamber 48 is unsplinted as shown in FIG. 36 A1, the original cross-sectional area of the cylinder is equal to A2 where θ=180°, h=0 and l=2R2. Volume equals A2 times length L and circumferential wall tension equals pressure within the chamber times R2 times the length L of the chamber. [0107] Thus, for example, with an original cylindrical radius of four centimeters and a pressure within the chamber of 140 mm of mercury, the wall tension T in the walls of the cylinder is 104.4 newtons. When a 3.84 cm splint is placed as shown in FIGS. 37 and 38 such that l=3.84 cm, the wall tension T is 77.33 newtons. [0108] [0108]FIGS. 39 and 40 show a hypothetical distribution of wall tension T and pressure P for the figure eight cross-section. As θ goes from 180° to 0°, tension Ts in the splint goes from 0 to a 2T load where the chamber walls carry a T load. [0109] In yet another example, assuming that the chamber length L is a constant 10 cm, the original radius R1 is 4 cm, at a 140 mmHg the tension in the walls is 74.7 N. If a 4.5 cm splint is placed such that l=4.5 cm, the wall tension will then be 52.8 N. [0110] It will be understood that this disclosure in many respects, is only illustrative. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims. Referenced byCiting PatentFiling datePublication dateApplicantTitleUS6723038Oct 6, 2000Apr 20, 2004Myocor, Inc.Methods and devices for improving mitral valve functionUS6746471May 25, 2001Jun 8, 2004Myocor, Inc.Transventricular implant tools and devicesUS6755777Dec 20, 2002Jun 29, 2004Myocor, Inc.Heart wall tension reduction apparatus and methodUS6764510Jan 9, 2002Jul 20, 2004Myocor, Inc.Devices and methods for heart valve treatmentUS6793618Dec 20, 2002Sep 21, 2004Myocor, Inc.Heart wall tension reduction apparatusUS6808488May 2, 2002Oct 26, 2004Myocor, Inc.External stress reduction device and methodUS7316706Jun 14, 2004Jan 8, 2008Medtronic Vascular, Inc.Tensioning device, system, and method for treating mitral valve regurgitationUS7666224Jul 7, 2005Feb 23, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7678135Apr 14, 2006Mar 16, 2010Usgi Medical, Inc.Compressible tissue anchor assembliesUS7678145Jul 1, 2005Mar 16, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7695425Feb 17, 2004Apr 13, 2010Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7695493Jun 9, 2004Apr 13, 2010Usgi Medical, Inc.System for optimizing anchoring forceUS7703459Sep 29, 2004Apr 27, 2010Usgi Medical, Inc.Apparatus and methods for mapping out endoluminal gastrointestinal surgeryUS7704264Nov 17, 2004Apr 27, 2010Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS7722523Jul 9, 2002May 25, 2010Edwards Lifesciences LlcTransventricular implant tools and devicesUS7736374Mar 1, 2005Jun 15, 2010Usgi Medical, Inc.Tissue manipulation and securement systemUS7736378May 7, 2004Jun 15, 2010Usgi Medical, Inc.Apparatus and methods for positioning and securing anchorsUS7736379Jul 11, 2005Jun 15, 2010Usgi Medical, Inc.Compressible tissue anchor assembliesUS7744613Dec 12, 2003Jun 29, 2010Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS7766812Apr 14, 2006Aug 3, 2010Edwards Lifesciences LlcMethods and devices for improving mitral valve functionUS7883539Apr 23, 2002Feb 8, 2011Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7918845Nov 16, 2004Apr 5, 2011Usgi Medical, Inc.Endoluminal tool deployment systemUS7918869May 7, 2004Apr 5, 2011Usgi Medical, Inc.Methods and apparatus for performing endoluminal gastroplastyUS7942884Jul 1, 2003May 17, 2011Usgi Medical, Inc.Methods for reduction of a gastric lumenUS7942898Jul 1, 2003May 17, 2011Usgi Medical, Inc.Delivery systems and methods for gastric reductionUS7955340Dec 12, 2003Jun 7, 2011Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS7981020Jun 5, 2008Jul 19, 2011Edwards Lifesciences LlcTransventricular implant tools and devicesUS8057511May 7, 2004Nov 15, 2011Usgi Medical, Inc.Apparatus and methods for positioning and securing anchorsUS8066719Nov 18, 2004Nov 29, 2011Ewers Richard CApparatus and methods for forming gastrointestinal tissue approximationsUS8070805Jan 25, 2010Dec 6, 2011Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS8092363Sep 5, 2007Jan 10, 2012Mardil, Inc.Heart band with fillable chambers to modify heart valve functionUS8092367May 16, 2008Jan 10, 2012Mardil, Inc.Method for external stabilization of the base of the heartUS8128553Dec 12, 2006Mar 6, 2012Mardil, Inc.Method and apparatus for external stabilization of the heartUS8187323Oct 19, 2001May 29, 2012Edwards Lifesciences, LlcValve to myocardium tension members device and methodUS8206417Jun 9, 2004Jun 26, 2012Usgi Medical Inc.Apparatus and methods for optimizing anchoring forceUS8216252Mar 1, 2005Jul 10, 2012Usgi Medical, Inc.Tissue manipulation and securement systemUS8216253Apr 22, 2008Jul 10, 2012Usgi Medical, Inc.Apparatus for manipulating and securing tissueUS8216260Aug 25, 2008Jul 10, 2012Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS8226711Jul 1, 2005Jul 24, 2012Edwards Lifesciences, LlcValve to myocardium tension members device and methodUS8236009Oct 14, 2009Aug 7, 2012Usgi Medical, Inc.Needle assembly for tissue manipulationUS8257394Jan 14, 2005Sep 4, 2012Usgi Medical, Inc.Apparatus and methods for positioning and securing anchorsUS8262676Sep 18, 2009Sep 11, 2012Usgi Medical, Inc.Apparatus and methods for forming gastrointestinal tissue approximationsUS8267852Jul 8, 2010Sep 18, 2012Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8298291Apr 26, 2006Oct 30, 2012Usgi Medical, Inc.Methods and apparatus for securing and deploying tissue anchorsUS8308765May 7, 2004Nov 13, 2012Usgi Medical, Inc.Apparatus and methods for positioning and securing anchorsUS8343175Apr 26, 2010Jan 1, 2013Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS8382800Mar 15, 2010Feb 26, 2013Usgi Medical, Inc.Compressible tissue anchor assembliesUS8439817Feb 17, 2005May 14, 2013Edwards Lifesciences, LlcChordae capturing methods for stress reductionUS8444657Apr 28, 2005May 21, 2013Usgi Medical, Inc.Apparatus and methods for rapid deployment of tissue anchorsUS8449442Dec 20, 2007May 28, 2013Bioventrix, Inc.Method and device for percutaneous left ventricular reconstructionUS8460173Sep 11, 2012Jun 11, 2013Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8491455 *Oct 3, 2008Jul 23, 2013Bioventrix, Inc.Treating dysfunctional cardiac tissueUS8506474Aug 21, 2006Aug 13, 2013Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissueUS8506624Dec 2, 2011Aug 13, 2013Edwards Lifesciences, LlcDevices and methods for heart valve treatmentUS8574243Dec 12, 2003Nov 5, 2013Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue foldsUS8579798Jun 5, 2008Nov 12, 2013Edwards Lifesciences, LlcExternal cardiac stress reduction methodUS8636639Jan 24, 2012Jan 28, 2014Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beatUS8685044Jun 13, 2012Apr 1, 2014Aptus Endosystems, Inc.Systems and methods for attaching a prosthesis with a body lumen or hollow organUS8690897Nov 2, 2010Apr 8, 2014Aptus Endosystems, Inc.Devices, systems, and methods for prosthesis delivery and implantation, including the use of a fastener toolUS8726909Jan 27, 2006May 20, 2014Usgi Medical, Inc.Methods and apparatus for revision of obesity proceduresUS8740940Jan 23, 2013Jun 3, 2014Usgi Medical, Inc.Compressible tissue anchor assembliesUS8828027Jun 14, 2010Sep 9, 2014U.S.G.I. Medical, Inc.Tissue manipulation and securement systemUS8870916Jul 5, 2007Oct 28, 2014USGI Medical, IncLow profile tissue anchors, tissue anchor systems, and methods for their delivery and useUS8926634Dec 5, 2007Jan 6, 2015Usgi Medical, Inc.Apparatus and methods for manipulating and securing tissueUS8968175Jul 23, 2013Mar 3, 2015Bioventrix, Inc.Treating dysfunctional cardiac tissueUS8979750Sep 30, 2012Mar 17, 2015Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditionsUS8986189Jul 1, 2010Mar 24, 2015Bioventrix, Inc.Method and apparatus for closing off a portion of a heart ventricleUS9023065Jun 9, 2011May 5, 2015Aptus Endosystems, Inc.Devices, systems, and methods for supporting tissue and/or structures within a hollow body organUS9039594Jan 28, 2014May 26, 2015Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beatUS9044231Mar 11, 2013Jun 2, 2015Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failureUS9095363Sep 30, 2012Aug 4, 2015Bioventrix, Inc.Remote pericardial hemostasis for ventricular access and reconstruction or other organ therapiesUS9119720May 20, 2013Sep 1, 2015Bioventrix, Inc.Method and device for percutaneous left ventricular reconstructionUS9173711Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Cardiac implant migration inhibiting systemsUS9173712Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Over-the-wire cardiac implant delivery system for treatment of CHF and other conditionsUS9198757Jul 7, 2009Dec 1, 2015Edwards Lifesciences, LlcMethods and devices for improving mitral valve functionUS9211115May 21, 2007Dec 15, 2015Bioventrix, Inc.Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease statesUS9259319Aug 13, 2013Feb 16, 2016Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissueUS9320503Oct 20, 2005Apr 26, 2016Medtronic Vascular, Inc.Devices, system, and methods for guiding an operative tool into an interior body regionUS9320513Mar 13, 2015Apr 26, 2016Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditionsUS9320589Jun 16, 2011Apr 26, 2016Medtronic Vascular, Inc.Endovascular aneurysm repair systemUS9320591Mar 31, 2014Apr 26, 2016Medtronic Vascular, Inc.Devices, systems, and methods for prosthesis delivery and implantation, including the use of a fastener toolUS9370425Oct 14, 2013Jun 21, 2016Mardil, Inc.Cardiac treatment system and methodUS9402722May 27, 2015Aug 2, 2016Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failureUS9421101Oct 14, 2013Aug 23, 2016Mardil, Inc.Cardiac treatment systemUS9421102Oct 14, 2013Aug 23, 2016Mardil, Inc.Cardiac treatment system and methodUS9486206Mar 2, 2015Nov 8, 2016Bioventrix, Inc.Treating dysfunctional cardiac tissueUS9510817Jun 7, 2012Dec 6, 2016Usgi Medical, Inc.Apparatus for manipulating and securing tissueUS9526618Aug 28, 2015Dec 27, 2016Bioventrix, Inc.Method and device for percutaneous left ventricular reconstructionUS9585651May 26, 2005Mar 7, 2017Usgi Medical, Inc.Methods and apparatus for securing and deploying tissue anchorsUS20020077524 *Feb 14, 2002Jun 20, 2002Myocor, Inc.Heart wall tension reduction apparatusUS20030045771 *Aug 15, 2002Mar 6, 2003Schweich Cyril J.Heart wall tension reduction devices and methodsUS20030050529 *Oct 24, 2002Mar 13, 2003Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assemblyUS20040127983 *Oct 7, 2003Jul 1, 2004Myocor, Inc.Valve to myocardium tension members device and methodUS20040167374 *Feb 17, 2004Aug 26, 2004Myocor, Inc.Heart wall tension reduction apparatus and methodUS20040260317 *Jun 14, 2004Dec 23, 2004Elliot BloomTensioning device, system, and method for treating mitral valve regurgitationUS20040267329 *Mar 8, 2004Dec 30, 2004Mardil, Inc.Method and apparatus for external heart stabilizationUS20050065396 *Jul 27, 2004Mar 24, 2005Myocor, Inc.External stress reduction device and methodUS20050251205 *May 7, 2004Nov 10, 2005Usgi Medical Inc.Apparatus and methods for positioning and securing anchorsUS20050251206 *May 7, 2004Nov 10, 2005Usgi Medical CorporationApparatus and methods for positioning and securing anchorsUS20050277981 *Jun 9, 2004Dec 15, 2005Usgi Medical Inc.Apparatus and methods for optimizing anchoring forceUS20050277983 *Jun 9, 2004Dec 15, 2005Usgi Medical Inc.System for optimizing anchoring forceUS20060089711 *Sep 22, 2005Apr 27, 2006Medtronic Vascular, Inc.Multifilament anchor for reducing a compass of a lumen or structure in mammalian bodyUS20060217762 *Apr 14, 2006Sep 28, 2006Usgi Medical, Inc.Compressible tissue anchor assembliesUS20070025009 *Jul 19, 2006Feb 1, 2007Fuji Photo Film Co., Ltd.Magnetic recorderUS20070066863 *Aug 31, 2006Mar 22, 2007Medtronic Vascular, Inc.Device for treating mitral valve regurgitationUS20070073274 *Aug 21, 2006Mar 29, 2007Sing-Fatt ChinMethod and device for treating dysfunctional cardiac tissueUS20070203391 *Feb 23, 2007Aug 30, 2007Medtronic Vascular, Inc.System for Treating Mitral Valve RegurgitationUS20070265658 *May 12, 2006Nov 15, 2007Aga Medical CorporationAnchoring and tethering systemUS20080097148 *Dec 20, 2007Apr 24, 2008Chf Technologies, Inc.Method and device for percutaneous left ventricular reconstructionUS20080294251 *May 21, 2007Nov 27, 2008Bioventrix (A Chf Technologies' Company)Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease statesUS20080319256 *Jun 5, 2008Dec 25, 2008Myocor, Inc.Transventricular implant tools and devicesUS20090062596 *Sep 5, 2007Mar 5, 2009Leinsing Karl RHeart band with fillable chambers to modify heart valve functionUS20090082852 *Nov 26, 2008Mar 26, 2009Aptus Endosystems, Inc.Catheter-based fastener implantation apparatus and methodsUS20090093670 *Oct 3, 2008Apr 9, 2009Bioventrix (A Chf Technologies, Inc.)Treating Dysfunctional Cardiac TissueUS20090099650 *Oct 16, 2008Apr 16, 2009Lee BolducDevices, systems, and methods for endovascular staple and/or prosthesis delivery and implantationUS20090112303 *Oct 16, 2008Apr 30, 2009Lee BolducDevices, systems, and methods for endovascular staple and/or prosthesis delivery and implantationUS20090137863 *Dec 2, 2008May 28, 2009Myocor, Inc.Heart wall tension reduction apparatusUS20100268020 *Jul 1, 2010Oct 21, 2010Bioventrix (A Chf Technologies, Inc.)Method and Apparatus For Closing Off a Portion of a Heart VentricleUS20110087320 *Nov 9, 2010Apr 14, 2011Aptus Endosystems, Inc.Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis AssemblyUS20110238088 *Jun 9, 2011Sep 29, 2011Aptus Endosystems, Inc.Devices, systems, and methods for supporting tissue and/or structures within a hollow body organUSD717954Oct 14, 2013Nov 18, 2014Mardil, Inc.Heart treatment deviceCN100525719CFeb 22, 2005Aug 12, 2009阿普特斯内系统公司Systems for supporting tissue and/or structures within a hollow body organWO2013049766A1 *Sep 30, 2012Apr 4, 2013Bioventrix, Inc.Over-the-wire cardiac implant delivery system for treatment of chf and other conditions* Cited by examinerClassifications U.S. Classification600/16International ClassificationA61B19/00, A61M31/00, A61B17/04, A61B17/12, A61B17/00, A61F2/00, A61B17/122, A61F2/02, A61N1/362Cooperative ClassificationY10S623/91, A61B2017/0404, A61B2017/0435, A61B2017/00243, A61B2017/0429, A61F2/2487, A61B2017/0417, A61B2017/0461, A61B2017/0496, A61B17/1227, A61F2/2481, A61B17/00234, A61B2017/048European ClassificationA61B17/00E, A61F2/24W4Legal EventsDateCodeEventDescriptionAug 4, 2006FPAYFee paymentYear of fee payment: 4Sep 5, 2007ASAssignmentOwner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIAFree format text: SECURITY AGREEMMENT;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:019805/0072Effective date: 20070820Owner name: VENTURE LENDING & LEASING IV, INC.,CALIFORNIAFree format text: SECURITY AGREEMMENT;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:019805/0072Effective date: 20070820Feb 16, 2009ASAssignmentOwner name: EDWARDS LIFESCIENCES LLC, CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:022277/0011Effective date: 20081029Owner name: EDWARDS LIFESCIENCES LLC,CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:022277/0011Effective date: 20081029Aug 4, 2010FPAYFee paymentYear of fee payment: 8Oct 19, 2010ASAssignmentOwner name: MYOCOR, INC., MINNESOTAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCHWEICH, CYRIL J., JR.;MORTIER, TODD J.;REEL/FRAME:025163/0127Effective date: 19970102Jul 28, 2014FPAYFee paymentYear of fee payment: 12RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services